PAVmed
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $33 | $22 | $52 | $5 |
Gross Profit | -89 | -95 | -51 | -50 |
EBITDA | -6,596 | -1,041 | -2,734 | -5,981 |
EBIT | -1,061 | -2,752 | -6,003 | |
Net Income | -5,384 | -60 | -1,263 | -5,383 |
Net Change In Cash | 33 | 22 | 52 | 5 |
Free Cash Flow | -2,676 | -2,620,000 | -1,565 | -899 |
Cash | 3,784 | 6,460 | 1,538 | 3,103 |
Basic Shares | 6,269 | 1,580 | 773 | 718 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $71 | $2,995 | $2,452 | $377 |
Gross Profit | -252 | -3,043 | -3,968 | -3,237 |
EBITDA | -2,343 | 29,670 | -75,742 | -99,500 |
EBIT | -2,448 | 28,472 | -78,674 | -101,957 |
Net Income | 401 | 39,791 | -64,175 | -88,983 |
Net Change In Cash | 71 | 2,995 | 2,452 | 377 |
Free Cash Flow | -5,206,000 | -33,609 | -52,278 | -72,525 |
Cash | 1,538 | 1,185 | 19,639 | 39,744 |
Basic Shares | 670 | 2,176 | 241 | 197 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.42 |
2026-03-31 | -$1.17 |
2025-12-31 | -$1.05 |
2025-09-30 | -$0.60 |